Carcinogenic talc: Johnson & Johnson is considering a structural change

Against the background of thousands of claims of casualties and a business dispute with suppliers, the pharmaceutical giant is examining the transfer of talcum products to a separate unit. The plaintiffs sought to halt the move for fear the company would remove liability for damages. But a U.S. court has ruled that it can not prevent Johnson & Johnson from taking future business steps

Back to top button